Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-05-15 3:20 pm Purchase |
2025-03-31 | 13G | VolitionRx Limited VNRX |
Armistice Capital, LLC | 9,804,352 9.990% |
461,087![]() (+4.93%) |
Filing History |
2025-05-15 3:19 pm Purchase |
2025-03-31 | 13G | Kairos Pharma, Ltd. KAPA |
Armistice Capital, LLC | 1,696,924 9.990% |
1,696,924![]() (New Position) |
Filing History |
2025-05-15 3:19 pm Purchase |
2025-03-31 | 13G | Treace Medical Concepts, Inc. TMCI |
Armistice Capital, LLC | 6,211,000 9.920% |
2,000![]() (+0.03%) |
Filing History |
2025-05-15 3:18 pm Purchase |
2025-03-31 | 13G | KINETA INC KANT |
Armistice Capital, LLC | 1,366,816 9.990% |
722,838![]() (+112.25%) |
Filing History |
2025-05-15 3:18 pm Purchase |
2025-03-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN |
Armistice Capital, LLC | 5,196,000 9.280% |
360,000![]() (+7.44%) |
Filing History |
2025-05-15 3:17 pm Purchase |
2025-03-31 | 13G | Steakholder Foods Ltd. STKH |
Armistice Capital, LLC | 293,941 7.050% |
224,644![]() (+324.17%) |
Filing History |
2025-05-15 3:17 pm Purchase |
2025-03-31 | 13G | Inspire Veterinary Partners, Inc. IVP |
Armistice Capital, LLC | 212,725 9.990% |
212,725![]() (New Position) |
Filing History |
2025-05-15 3:16 pm Purchase |
2025-03-31 | 13G | SeaStar Medical Holding Corporation ICU |
Armistice Capital, LLC | 1,019,958 9.990% |
1,019,958![]() (New Position) |
Filing History |
2025-05-15 3:16 pm Purchase |
2025-03-31 | 13G | Helius Medical Technologies, Inc. HSDT |
Armistice Capital, LLC | 871,134 9.990% |
871,134![]() (New Position) |
Filing History |
2025-05-15 3:15 pm Purchase |
2025-03-31 | 13G | GeoVax Labs, Inc. GOVX |
Armistice Capital, LLC | 1,612,729 9.990% |
1,117,140![]() (+225.42%) |
Filing History |
2025-05-15 3:15 pm Purchase |
2025-03-31 | 13G | Curis, Inc. CRIS |
Armistice Capital, LLC | 1,046,489 9.990% |
1,046,489![]() (New Position) |
Filing History |
2025-05-15 3:14 pm Purchase |
2025-03-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Armistice Capital, LLC | 3,359,661 9.990% |
3,359,661![]() (New Position) |
Filing History |
2025-05-15 3:14 pm Sale |
2025-03-31 | 13G | XORTX Therapeutics Inc. XRTX |
Armistice Capital, LLC | 178,031 4.990% |
-168,776![]() (-48.67%) |
Filing History |
2025-05-15 3:13 pm Sale |
2025-03-31 | 13G | Vincerx Pharma, Inc. VINC |
Armistice Capital, LLC | 274,908 4.990% |
-4,200,213![]() (-93.86%) |
Filing History |
2025-05-15 3:13 pm Purchase |
2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX |
Armistice Capital, LLC | 8,872,000 9.990% |
1,514,000![]() (+20.58%) |
Filing History |
2025-05-15 3:12 pm Purchase |
2025-03-31 | 13G | CERo Therapeutics Holdings, Inc. CERO |
Armistice Capital, LLC | 584,548 9.990% |
584,548![]() (New Position) |
Filing History |
2025-05-15 3:12 pm Purchase |
2025-03-31 | 13G | Creative Medical Technology Holdings, Inc. CELZ |
Armistice Capital, LLC | 148,000 5.720% |
148,000![]() (New Position) |
Filing History |
2025-05-15 3:11 pm Sale |
2025-03-31 | 13G | Kartoon Studios Inc. TOON |
Armistice Capital, LLC | 2,294,582 4.990% |
-2,312,574![]() (-50.20%) |
Filing History |
2025-05-15 3:10 pm Purchase |
2025-03-31 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP |
Armistice Capital, LLC | 77,357 4.990% |
77,357![]() (New Position) |
Filing History |
2025-05-15 3:10 pm Purchase |
2025-03-31 | 13G | Cibus, Inc. CBUS |
Armistice Capital, LLC | 1,948,000 5.970% |
1,948,000![]() (New Position) |
Filing History |